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l-Citrulline Supplementation-Increased Skeletal Muscle
PGC-1α Expression Is Associated with Exercise
Performance and Increased Skeletal Muscle Weight
Myra O. Villareal, Toshiya Matsukawa, and Hiroko Isoda*
Scope: l-citrulline has recently been reported as a more eﬀective supplement
for promoting intracellular nitric oxide (NO) production compared to
l-arginine. Here, the eﬀect of l-citrulline on skeletal muscle and its inﬂuence
on exercise performance were investigated. The underlying mechanism of its
eﬀect, speciﬁcally on the expression of skeletal muscle peroxisome proliferator-
activated receptor-gamma coactivator-1α (PGC-1α), was also elucidated.
Methods and results: Six-week-old ICR mice were orally supplemented with
l-citrulline (250 mg kg−1) daily, and their performance in weight-loaded
swimming exercise every other day for 15 days, was evaluated. In addition,
mice muscles were weighed and evaluated for the expression of PGC-1α and
PGC-1α-regulated genes. Mice orally supplemented with l-citrulline had
signiﬁcantly higher gastrocnemius and biceps femoris muscle mass. Although
not statistically signiﬁcant, l-citrulline prolonged the swimming time to
exhaustion. PGC-1α upregulation was associated with vascular endothelial
growth factor α (VEGFα) and insulin-like growth factor 1 (IGF-1) upregulation.
VEGFα and IGF-1 are important for angiogenesis and muscle growth,
respectively, and are regulated by PGC-1α. Treatment with NG-nitro-l-arginine
methyl ester hydrochloride (l-NAME), a nitric oxide synthesis inhibitor,
suppressed the l-citrulline-induced PGC-1α upregulation in vitro.
Conclusion: Supplementation with l-citrulline upregulates skeletal muscle
PGC-1α levels resulting in higher skeletal muscle weight that improves time
to exhaustion during exercise.
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1. Introduction
Regular exercise and being active
physically enhance endurance during
exercise and more importantly, improve
metabolic dysfunction that may help
prevent lifestyle-related diseases.[1,2]
Physical inactivity increases the risk
of development of obesity, type 2 dia-
betes, sarcopenia, hypertension, and
cardiovascular diseases.[3] Physically
active people’s life expectancy, without
long-standing illness, is in fact 8–10
years longer compared to that of inactive
people.[4] Several studies have demon-
strated that enhancement of the skeletal
muscle functions is observed to be the
major positive impact of exercise.[1,2]
This means that enhancing the skeletal
muscle functions, in terms of improved
mitochondrial biogenesis, capillaries,
and fatty acid transporters, signiﬁcantly
improve exercise capacity.
Peroxisome proliferator-activated
receptor-gamma coactivator-1α (PGC-
1α) is the transcriptional coactivator re-
sponsible for the regulation of mitochon-
drial biogenesis, angiogenesis, oxidative
metabolism, andmuscle growth, and has
a crucial role in the adaptation ofmuscles
to exercise.[5,6] Muscle-speciﬁc overexpression of PGC-1α in-
creases exercise capacity and improves maximal oxygen uptake
(VO2max) by increasing mitochondrial biogenesis and capillary
density in skeletal muscle.[7] Skeletal muscle PGC-1α is known to
have an important role in exercise adaptation and enhancement
of exercise capacity.[8,9]
Nitric oxide (NO) is a reactive nitrogen molecule synthe-
sized enzymatically through the catalytic action of nitric ox-
ide synthase (NOS). NO is expressed in the skeletal muscles
of mammals and acts as a second messenger in transduction
pathways associated with the expression of genes for oxidative
metabolism, vasodilation, and skeletal muscle contraction. NOS
inhibition also reduces the maximal oxygen uptake during exer-
cise in humans.[10] Conversely, increased intracellular NO pro-
duction leads to phosphorylation of CREB that in turn induces
PGC-1α expression.[11] Thus, several studies have indicated that
the physiological amount of NO positively impacts adaptation
to exercise, much so that nitrate supplementation has been
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considered to be an ergogenic supplementation for athletes or in
sports.[12,13]
Normally, physiological NO is derived from l-arginine. How-
ever, absorption of orally administered l-arginine is hampered
by ﬁrst-pass and systemic metabolism. l-citrulline, on the other
hand, is only subject to systemic metabolism. l-citrulline, a
nonessential amino acid, has recently been recognized as an ef-
fective alternative source of NO, and therefore can be taken as
a dietary supplement to increase intracellular NO production.[14]
Oral supplementation with l-citrulline increases NO levels by in-
creasing endothelial NO synthase (eNOS) expression that results
in improved endothelial function.[15,16] Neuronal NOS (nNOS)
and eNOS are also expressed in the skeletalmuscle.[11] l-citrulline
is a precursor of l-arginine but has several functional advantages
over l-arginine.[14,15] l-citrulline is superior to l-arginine in terms
of ease of handling and palatability since it is tasteless, odorless,
and non-hygroscopic, whereas l-arginine tends to be extremely
bitter and highly water absorbent.[17] Therefore, l-citrulline is
considered to be more eﬀective in enhancing exercise perfor-
mance by virtue of its eﬀect on skeletalmuscle regulation. Several
studies have reported that l-citrulline supplementation enhances
exercise performance[18–20]; however, the underlying mechanism
of its eﬀect on skeletal muscles and exercise performance, has
yet to be elucidated. In this study, the eﬀect of l-citrulline supple-
mentation on exercise and the underlying cause of those eﬀects
were investigated in vivo, using exercised mice, and in vitro, us-
ing skeletal muscle cells.
2. Experimental Section
2.1. Chemicals
Rhodamine 123, l-NAME, and sodium dodecyl sulfate (SDS)
were purchased from Wako (Tokyo, Japan). ISOGEN was pur-
chased from Nippongene (Tokyo, Japan). DMEM, RIPA buﬀer,
protease inhibitor cocktail, and β-Actin antibody were purchased
from Sigma (MO, USA). Fetal bovine serum (FBS) and house
serum (HS) were purchased from Gibco (NY, USA). MTT or
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
and l-NAME were purchased from Dojindo (Kumamoto, Japan).
l-citrulline was supplied by Kyowa Hakko Bio Co., Ltd., Tokyo,
Japan) while PGC-1α (3G6) antibody was purchased from Cell
Signaling Technology (Hertfordshire, UK). Glyceraldehyde
3-phosphate dehydrogenase (GAPDH) antibody (6C5) was
purchased from Santa Cruz Biotechnology (CA, USA).
2.2. Animal Experiments
Five-week-old male ICR mice were obtained from Charles River
Laboratories (Kanagawa, Japan) and maintained under a 12-h
light/dark cycle, with free access to water and a normal diet
(MF, Oriental Yeast Co., Ltd., Japan). Body weight was mea-
sured daily while food intake was measured once a week. After
1 week of acclimatization, the mice were divided into three
groups. Group 1 (“no exercise” group) was orally administered
with distilled water (D.W.) without swimming exercise (n = 6).
Group 2 (control group) was orally administered with water.
Group 3 (l-citrulline group) was orally administered with 250mg
kg−1 day of l-citrulline. The l-citrulline dose used in this study
was based on Takeda et al.’s[21] study. Both Groups 2 and 3 per-
formed swimming exercises (n = 7 per group). Oral administra-
tion of 100 μL sample solution was done using animal-feeding
needles (Group 1 and 2: D.W. orGroup 3: 250mg kg−1 l-citrulline
dissolved in water) every day for 15 days, 1 h before the swim-
ming exercise, and at the same time on “no exercise” days. The
exercise protocol was adapted from Takeda et al.[21] with some
modiﬁcations. Brieﬂy, mice with a load corresponding to 5% of
their body weight attached to their tails, were trained to perform
the swimming exercise for 10 min, in a tank (30 × 30 × 40 cm)
ﬁlled with water to a depth of 25 cm., with water temperature
kept at 30 ± 1 °C. The swimming exercise was performed every
other day for 14 days. On day 15, the mice were made to swim
to exhaustion with a load corresponding to 10% of their body
weight. Each mouse was considered to have reached its point
of exhaustion when it failed to raise its face from the water sur-
face to breathe within a period of 5 s. Blood lactate levels were
measured before and after exercise (0 and 60 min) using Lac-
tate Pro 2 (Arkrey, Japan). Blood glucose levels were measured
after exercise (0 min) using Glucose Pilot system (Iwai Chemi-
cals Company, Japan). The mice were sacriﬁced and blood and
tissues from the liver, gastrocnemius, and biceps femoris were
collected. The serum was separated from the blood by centrifu-
gation at 3000 × g for 10 min and the serum biochemical pa-
rameters (BUN, creatinine, total ketone bodies, AST, ALT, ALP,
nonessential fatty acid [NEFA]) were analyzed by Oriental Yeast
Co., Ltd., (Japan) using test kits obtained fromWako Pure Chemi-
cal Industries (Osaka, Japan). All animal experiments performed
are in compliance with the guidelines and regulations for Animal
Experiments of the University of Tsukuba (No. 16-044), and were
approved by the International Animal Care and Use Committee
of the University of Tsukuba.
2.3. Real-Time PCR Analysis
Total RNA was isolated from tissue samples (50 mg) and
C2C12 myotubes using ISOGEN. For C2C12 myotubes, cells
were treated with or without l-citrulline or NOS inhibitor
l-NAME. Total RNA isolation and TaqMan real-time PCR am-
pliﬁcation reactions were performed as previously reported.[22]
For the quantiﬁcation of the gene expression in muscle tis-
sues and C2C12 myotubes, the following speciﬁc TaqMan
probes purchased from Applied Biosystems (CA, USA) were
used: β-actin (Mm00607939 s1), PGC-1α (Mm01208835 m1),
LDHa (Mm01612132 g1), LDHb (Mm01267402 m1), MCT1
(Mm01306379 m1), CPT-1β (Mm00487191 g1), TFAM
(Mm00447485 m1), vascular endothelial growth factor α
(VEGFα) (Mm00437306 m1), and insulin-like growth factor 1
(IGF-1) (Mm00439560 m1). The mRNA levels of all genes were
normalized to β-actinmRNA levels (internal control).
2.4. Western Blotting
Total protein was isolated from tissue samples (10 mg) using
RIPA buﬀer containing a protease inhibitor cocktail according to
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the manufacturer’s instructions. Protein samples (15 μg) were
separated using 10% SDS-PAGE and transferred to a PVDF
membrane (Merck Millipore, USA). Membranes were incubated
with primary antibody at 4 °C overnight, then washed, and incu-
bated with secondary antibodies (IRDye 800CW donkey antirab-
bit IgG or IRDye 680LT goat antimouse [LI-COR, Inc., NE, USA])
at room temperature for 30 min. The signal was detected using
the Odyssey Fc Imaging System (LI-COR, Inc., NE, USA).
2.5. Cell Culture and Diﬀerentiation
The mouse C2C12 myoblasts (ATCC, USA) were cultured in
DMEM supplemented with 10% FBS and 1% penicillin (5000 μg
mL−1)–streptomycin (5000 IU mL−1) (Lonza, Tokyo, Japan). To
induce C2C12 myoblasts to diﬀerentiate into C2C12 myotubes,
C2C12 cells were cultured until conﬂuent and then transferred
to DMEM containing 2% horse serum, and incubated further for
5 days with the growth medium changed every other day.
2.6. MTT Assay
Following treatment and incubation with l-citrulline at diﬀer-
ent concentrations, MTT solution (5 mg mL−1) was added to the
C2C12 myotubes culture and incubated further for 3 h until for-
mazan crystals were formed. Formazan crystals were then dis-
solved by adding 10% SDS and the plates incubated further for
16 h. The absorbance at 570 nmwasmeasured using a Powerscan
HT plate reader (Dainippon Sumitomo Pharma Co, Ltd., Japan).
2.7. Statistical Analysis
All the results are expressed as the mean ± standard devia-
tion, and statistical evaluation was performed using the Student’s
t-test when two value sets were compared. Analysis that includes
multiple comparisons were carried out using one-way analysis
of variance or ANOVA, followed by Tukey’s multiple comparison
test using SPSS (IBM Statistics for Windows, version 22.0. IBM
Corp., Armonk, NY). p  0.05 was considered to be statistically
signiﬁcant.
3. Results
3.1. l-Citrulline Supplementation before Exercise Prevented
Exercise-Induced Elevation of Blood Lactate and Decrease
in Glucose Levels
To examine the eﬀect of l-citrulline supplementation on blood
lactate and glucose levels during exercise, mice were orally ad-
ministered with l-citrulline or water (control), 1 h before ex-
ercise, for 15 days. On day 13, mice were made to perform
weight-loaded forced swimming test for 10 min, and 1 h later,
were given l-citrulline supplementation (Figure 1). Changes in
the blood lactate levels during exercise are associated with exer-
cise performance. Lactate that accumulates in the muscles pro-
duces H+ ions that cause fatigue, impairing muscle function
and performance.[23] As shown in Figure 2A, before exercise, the
blood lactate levels between the control and l-citrulline groups
were not signiﬁcantly diﬀerent. However, after exercise, the lac-
tate level of the l-citrulline group was lowered (9.7 ± 2.0 mM vs.
7.3 ± 0.5 mM, p = 0.055). The diﬀerence in the lactate levels be-
fore and after exercise however, was bigger in the control group.
Lactate is produced when glucose or glycogen is used as a fuel
source, so that an increase in the glucose levels would lead to
higher lactate levels. Additionally, the l-citrulline group had sig-
niﬁcantly higher glucose levels after exercise on day 13 compared
to the control (142 ± 26.8 mg dL−1 vs. 174 ± 21.5 mg dL−1, p =
0.04) (Figure 2B).
3.2. l-Citrulline Supplementation before Exercise Increased
Muscle Weight and Increased Time to Exhaustion in Swimming
To evaluate the eﬀect of l-citrulline supplementation on exercise
performance, mice were made to perform a weight-loaded forced
swimming test until exhaustion, with a load corresponding to
10% of their body weight, 1 h after l-citrulline supplementation
(Figure 1). As shown in Figure 3A, the l-citrulline group had
longer time to exhaustion, though it was not statistically signiﬁ-
cant, compared to that of the control groups (270± 64.4 s vs. 537
± 285.2 s, p = 0.07). Although the mice in the l-citrulline sup-
plementation group swam for a longer period of time than the
control group, the lactate levels between these groups were not
signiﬁcantly diﬀerent (12.6 ± 0.7 mM vs. 14.0 ± 2.6 mM, p =
0.27) (Figure 3B). Also, compared to the control, the l-citrulline
group had signiﬁcantly lower blood glucose levels (153 ± 5.4 mg
dL−1 vs. 119 ± 7.9 mg dL−1, p < 0.01) (Figure 3C). Additionally,
l-citrulline supplementation showed an increase in the weight of
the gastrocnemius (0.23 ± 0.02 g vs. 0.28 ± 0.02 g, p = 0.02) and
biceps femoris muscles (0.34± 0.01 g vs. 0.52± 0.07 g, p< 0.01)
compared to the control, even though the body weights of both
groups were not signiﬁcantly diﬀerent (Table 1). The food intake,
including the amino acids from feeds, was also not signiﬁcantly
diﬀerent between the control and the l-citrulline-administered
groups (data not shown). Although other studies have reported
that l-citrulline elevates the levels of urea nitrogen, creatinine,
and total ketone bodies in the blood after exercise,[24,25] this study
shows that l-citrulline supplementation lowered the creatinine
level (0.20± 0.05 mg dL−1 vs. 0.14± 0.02 mg dL−1, p= 0.06) and
total ketone bodies (1163.3 ± 245.7 μM vs. 948.4 ± 206.6 μM,
p = 0.15) over time (Table 2).
3.3. l-Citrulline Supplementation Upregulated the PGC-1α
Expression in Gastrocnemius and Biceps Femoris
PGC-1α in the skeletal muscle has signiﬁcant regulatory role
in the muscles’ several adaptations to exercise such as lac-
tate metabolism, angiogenesis, and muscle growth.[1,5] Since the
gastrocnemius and biceps femoris are extensively used during
swimming, we speciﬁcally evaluated the eﬀects of l-citrulline
supplementation on the gastrocnemius and biceps femoris.
Supplementation with l-citrulline greatly increased PGC-1α
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Figure 1. Study design. Mice were made to perform a swimming exercise every other day for 14 days. A swimming-until-exhaustion test was carried out
on day 15. During the experimental period, mice were orally administrated with l-citrulline (250 mg kg−1) or distilled water (D.W.) every day.
Figure 2. Eﬀect of l-citrulline supplementation on the blood lactate and glucose levels after weight-loaded exercise performance. Mice orally admin-
istrated with l-citrulline (250 mg kg−1) or distilled water (D.W.) were made to perform a weight-loaded forced swimming test for 10 min on day 13.
A) Blood lactate levels before and after exercise (0 and 60 min) and B) blood glucose levels after exercise (0 min) were evaluated. Values are expressed
as the mean ± standard deviation. *p  0.05 and **p  0.01 indicate a signiﬁcant diﬀerence compared to the control group.
expression in the gastrocnemius (Figure 4A; 3.6 ± 0.5-fold,
p < 0.01) and biceps femoris (Figure 4B; 2.8 ± 0.6-fold, p <
0.01). As shown in Figure 5, the protein expression level of PGC-
1α in the gastrocnemius and biceps femoris (2.6 ± 0.7-fold,
p < 0.01 and 2.3 ± 0.8-fold, p = 0.02, respectively) was also
increased with l-citrulline supplementation. VEGFα and IGF-
1, cytokines released from skeletal muscle are important factors
for angiogenesis and muscle growth, respectively, and are under
the regulation of PGC-1α.[5] As shown in Figure 4, l-citrulline-
supplementedmice had signiﬁcantly higher levels ofVEGFα and
IGF-1 in their gastrocnemius (1.8 ± 0.3-fold, p < 0.01 and 1.3 ±
0.1-fold, p< 0.01, respectively) and biceps femoris (1.4± 0.2-fold,
p < 0.01 and 1.5 ± 0.2-fold, p < 0.01, respectively) compared to
the control group. The role of PGC-1α in the promotion of lac-
tate metabolism through increased lactate dehydrogenase (LDH)
B and monocarboxylate transporter 1 (MCT1) expression in the
skeletal muscle has already been established.[26] l-citrulline sup-
plementation also increased theMCT1 expression in the gastroc-
nemius (1.5 ± 0.4-fold, p = 0.05) and biceps femoris (1.3 ± 0.2-
fold, p< 0.05). The upregulation of LDHB, however, was only ob-
served in the gastrocnemius (1.6 ± 0.3-fold, p < 0.01) (Figure 4).
3.4. l-Citrulline-Induced PGC-1α Upregulation in C2C12
Myotubes was Suppressed by NO Synthesis Inhibition
To investigate the eﬀect of l-citrulline on the expression of PGC-
1α in the skeletal muscle cells, the eﬀective and non-cytotoxic
concentrations of citrulline were ﬁrst determined by performing
MTT assay using C2C12 myotubes, a cellular model of skeletal
muscle. l-citrulline treatment signiﬁcantly increased the prolif-
eration of C2C12 myotubes but a gradual decrease was observed
starting at concentrations of more than 500 μM l-citrulline
(Figure 6A). Considering the MTT assay results, 100 μM
l-citrulline was chosen as the best concentration to use in the
succeeding experiments. Treatment with 10, 50, and 100 μM
l-citrulline for 1 h increased the PGC-1α expression in C2C12
myotubes by 1.2 ± 0.1-fold, 1.4 ± 0.1-fold, and 1.5 ± 0.1-fold,
respectively (p < 0.01) (Figure 6B). l-citrulline is known to el-
evate intracellular NO levels by promoting NOS activity.[14–16]
Consequently, an elevation of intracellular NO production in-
creases muscle cell’s PGC-1α expression.[27] In the current study,
the upregulation of PGC-1α expression in C2C12 myotubes by
l-citrulline treatment was suppressed in the presence of NOS in-
hibitor l-NAME (Figure 6C).
4. Discussion
In the ﬁeld of sports physiology, nitrate supplementation is be-
lieved to be an eﬀective strategy for the enhancement of exercise
performance. Increased intracellular NO production increases
PGC-1α expression via phosphorylation of CREB.[11] The tran-
scriptional activator PGC-1α has an important role in the regula-
tion of genes associated with adaptation to exercise such as oxida-
tive metabolism, angiogenesis, and muscle growth.[1] It has been
reported that non-protein amino acids, (e.g., ornithine, citrulline,
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Figure 3. Eﬀect of l-citrulline supplementation on swimming endurance.
Mice were trained to perform swimming exercise every other day for 14
days, then a swimming-until-exhaustion test was carried out on day 15.
A) Swimming time to exhaustion, B) blood lactate levels before and after
exercise (0 and 60 min), and C) blood glucose levels after exercise (0 min)
were evaluated. Values are expressed as the mean ± standard deviation.
*p 0.05 and **p 0.01 indicate a signiﬁcant diﬀerence compared to the
control group. The individual raw data was plotted over the bar graph.
and homocysteine) which are not used for protein synthesis, play
an important role in cell metabolism.[28]
l-citrulline, a non-essential amino acid, has recently been
demonstrated to be eﬀective in increasing of intracellular NO
production by increasing NOS expression.[14–16] The major
ﬁndings of this study are that the upregulation of PGC-1α in the
skeletal muscle by l-citrulline is associated with increased exer-
cise performance and muscles weight. l-citrulline is a precursor
of l-arginine that is considered to be preferable than l-arginine
Table 1.Mice body weight, food intake, and tissue weight.
Swimming
No exercise Control l-citrulline
Initial body weight [g] 28.7 ± 1.3 28.2 ± 1.4 28.5 ± 0.8
Final body weight [g] 30.7 ± 1.2 31.6 ± 2.0 32.5 ± 1.7
Food intake [g day−1] 3.67 ± 0.12 3.64 ± 0.23 3.92 ± 0.32#
Kidney [g] 0.43 ± 0.01 0.50 ± 0.03** 0.45 ± 0.02#
Liver [g] 1.19 ± 0.04 1.18 ± 0.04 1.21 ± 0.06
Gastrocnemius [g] 0.24 ± 0.03 0.23 ± 0.02 0.28 ± 0.02*,##
Biceps femoris [g] 0.26 ± 0.03 0.34 ± 0.01** 0.52 ± 0.07**,#
Values are expressed as the mean ± standard deviation. *p  0.05 and **p  0.01
indicate a signiﬁcant diﬀerence from the “no exercise” group. #p  0.05 and ##p 
0.01 indicate a signiﬁcant diﬀerence compared to the control group.
Table 2. Level of serum biochemical parameters at the end of the study.
Swimming
No exercise Control l-citrulline
BUN [mg dL−1] 32.3 ± 0.9 23.9 ± 2.1** 23.3 ± 2.7**
Creatinine [mg dL−1] 0.15 ± 0.01 0.20 ± 0.05 0.14 ± 0.02
Total ketone bodies [μM] 593.3 ± 53.3 1163.3 ± 245.7** 948.4 ± 206.6*
AST [IU L−1] 1782.5 ± 280.9 1922.0 ± 461.2 1750.4 ± 238.1
ALT [IU L−1] 226.3 ± 3.5 226.8 ± 40.4 201.7 ± 23.7
ALP [IU L−1] 345.0 ± 17.9 433.7 ± 37.6** 369.4 ± 40.9#
NEFA [μEq L−1] 1125.8 ± 140.9 1298.2 ± 129.8 1180.3 ± 158.1
Values are expressed as the mean ± standard deviation. *p  0.05 and **p  0.01
indicate a signiﬁcant diﬀerence compared to the “no exercise” group. #p  0.05 in-
dicates a signiﬁcant diﬀerence compared to the control group. BUN, urea nitrogen;
AST, aspartate transaminase; ALT, alanine transaminase; ALP, alkaline phosphatase;
NEFA, non-esteriﬁed fatty acid.
in terms of solubility and taste, as well as several functional
advantages.[14,15,17] Moreover, l-arginine can enhance NO pro-
duction but it is rapidly metabolized in the small intestine and
liver when administered orally.[14] Therefore, when compared to
l-citrulline, l-citrulline comes out as a more eﬀective sports
supplement for enhancing sports performance compared
to l-arginine. Some studies, have reported that single sup-
plementation of l-citrulline does not help improve exercise
performance[21,29] suggesting the need for long-term supplemen-
tation of l-citrulline (more than 1 week) to eﬀectively enhance
exercise tolerance.[20,21] The current study also provides data
to validate assumptions of past researches that l-citrulline
supplementation for 15 days can enhance exercise performance
and increase muscle mass. The results of this study therefore
suggest that long-term intake of l-citrulline has a positive impact
on exercise performance.
Lactate is produced during intense exercise when the supply of
O2 is insuﬃcient. The blood lactate level during exercise is depen-
dent on the ratio of lactate production to lactate clearance.[23,30]
Hydrogen ions (H+) dissociate from lactic acid and accumulate
in the muscles, causing fatigue and depressing muscle function
and contraction.[23] In addition, decreased blood glucose levels
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Figure 4. Eﬀect of l-citrulline supplementation on the expression of PGC-1α and PGC-1α-related genes in the gastrocnemius and biceps femoris.
Expression levels of PGC-1α and PGC-1α-targeted genes in the A) gastrocnemius and B) biceps femoris were evaluated. Expression levels of mRNA
were normalized to the β-actin expression level. Values are expressed as the mean ± standard deviation and relative to the “no exercise” group. *p 
0.05 and **p  0.01 indicate a signiﬁcant diﬀerence compared to the control group.
Figure 5. Eﬀect of l-citrulline supplementation on the protein expression of PGC-1α in the gastrocnemius and biceps femoris. Protein expression levels of
PGC-1α in the A) gastrocnemius and B) biceps femoris were evaluated. All gels were run under the same experimental conditions and the representative
blots were shown. The protein expression levels were normalized to GAPDH expression. Values are expressed as the mean ± standard deviation and
relative to the unexercised group. *p  0.05 and **p  0.01 indicate a signiﬁcant diﬀerence from the control group.
(hypoglycemia) during exercise also causes fatigue and low en-
ergy, leading to exercise cessation.[31] The l-citrulline supple-
mented mice group had lower blood lactate levels and higher
glucose levels immediately after exercising with the same load
(Figure 2). These results therefore suggest that the observed inhi-
bition of lactate production and/or increased lactate metabolism
during exercise can be attributed to l-citrulline supplementation.
However, the blood lactate levels after exercise were not diﬀer-
ent from the after the swimming-to-exhaustion test blood lactate
levels (Figure 3). Following a swimming-to-exhaustion test, the
blood lactate levels gradually increase depending on the dura-
tion of the exercise.[32] In this study, l-citrulline supplemented
group had longer average swimming to exhaustion time com-
pared to the control (270 s vs. 537 s, respectively) (Figure 3A).
Therefore, it can be assumed that blood lactate levels before and
after the swimming-to-exhaustion test remained the same. Skele-
tal muscle PGC-1α promotes lactate metabolism by increasing
the expression of LDH B and MCT1, and conversely, prevents
lactate production by suppressing the expression of LDH A that
catalyzes the conversion of pyruvate to lactate.[1,26] A decrease
in LDH A expression and increase in MCT1 and LDH B levels
were also observed following l-citrulline supplementation (Fig-
ure 3). Several studies reported have established that l-citrulline
has antidiabetic and antiobesity eﬀects[33–35] but does not aﬀect
the blood glucose level. So, in this study, it can then be assumed
that l-citrulline did not aﬀect the blood glucose levels and in-
stead suggests that a decrease in lactate production and an in-
crease in lactate metabolism are therefore involved in the regu-
lation of blood lactate and glucose levels. PGC-1α mRNA level
is elevated after performing exercise but the level returns back
to its “before exercise level” during the rest period, speciﬁcally
within 24 h after exercise.[36,37] Even though the muscle samples
were collected 24 h after exercise, an increase in PGC-1α mRNA
and protein expression due to l-citrulline supplementation was
still observed (Figure 2). Therefore, it is clear that the increase in
lactate metabolism can be attributed to the longitudinal PGC-1 α
upregulation by l-citrulline rather than a transient upregulation
by exercise.
Increased blood ﬂow enhances not only exercise performance,
by improving nutrient and oxygen delivery in muscle, but also
by boosting protein synthesis and muscle ﬁber repair.[38] Several
reports have suggested that l-citrulline supplementation can im-
prove blood pressure, VO2 kinetics, and exercise performance
in healthy adults,[19,20] and believed to be due to PGC-1α upreg-
ulation in the muscles that promoted formation of new blood
vessels (angiogenesis), and thus, integrating oxygen/nutrient
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Figure 6. Eﬀect of l-citrulline on the gene expression of PGC-1α in C2C12
myotubes. Diﬀerentiated C2C12 myotubes were treated with or without
l-citrulline for 24 h. A) After that, cell viability was evaluated and value
expressed as percentage (%) of control. B) C2C12 myotubes were treated
with or without l-citrulline (10, 50, 100μM) for 1 h. C) l-citrulline (50μM)
treatment was performed with or without 100 μM NG-nitro-l-arginine
methyl ester hydrochloride (l-NAME) for 1 h. Following treatment, PGC-
1α mRNA levels were quantiﬁed using real-time PCR and the values nor-
malized to the expression level of β-actin. Values are expressed as the
mean± standard deviation of triplicate experiments. **p 0.01 indicates
a signiﬁcant diﬀerence from the control group. ##p  0.01 indicate a sig-
niﬁcant diﬀerence from the l-NAME-treated l-citrulline group.
consumption and supply. PGC-1α expression in cultured mus-
cle cells and in skeletal muscle promotes the expression of sev-
eral angiogenic factors, including VEGF, which plays a crucial
role in vascular development. At the same time, muscle vascu-
larization by VEGFα increases blood supply and oxygen avail-
ability in the muscle, increasing exercise time and endurance.[39]
In the current study, an l-citrulline-induced increase in skeletal
muscle VEGFα expression was observed (Figure 4), suggesting
that l-citrulline supplementation-induced angiogenesis in skele-
tal muscle can be associated with the observed increase in swim-
ming time. It is a well-known fact that oral supplementation
with l-citrulline elevates NO levels by increasing NOS expres-
sion, resulting in improved endothelial function.[15] On the other
hand, NOS inhibition has been established to reduce maximal
oxygen uptake during exercise in humans.[13] However, increased
intracellular NO production induces PGC-1α expression.[11] In
this study, l-citrulline-induced PGC-1α upregulation in C2C12
myotubes was suppressed by l-NAME, a NOS inhibitor (Fig-
ure 6), suggesting, therefore, that l-citrulline-increased skeletal
muscle PGC-1α level was due to the rise in the intracellular NO
production.
Several PGC-1α variants are expressed from alternative gene
promoter, namely PGC-1α-b and PGC-1α4, and have been
shown to induce VEGF expression in skeletal muscle and
angiogenesis.[40] Transgenic expression of PGC-1α4 in skeletal
muscle in mice induces angiogenesis in vivo.[40] PGC-1α4 also
activates a hypertrophic gene program in skeletalmuscle. In addi-
tion, PGC-1α4 also regulates skeletal muscle growth by inducing
the anabolic hormone IGF-1 and repressing myostatin, a pow-
erful inhibitor of muscle diﬀerentiation and growth.[7,41] In this
study, skeletal muscle weight was increased corresponding to
PGC-1α and IGF-1 upregulation by l-citrulline. It can therefore
be inferred from these results that l-citrulline induces PGC-1α4
in association with l-citrulline-induced VEGFα and IGF-1 upreg-
ulation. Elevated PGC-1α in muscle dramatically protects against
the sarcopenia, obesity, and diabetes that normally accompanies
aging.[42] Therefore, the use of l-citrulline to increase PGC-1α ex-
pression may be useful in the management of diseases such as
obesity, diabetes, and sarcopenia, as well as in the enhancement
of exercise performance.
5. Concluding Remarks
l-citrulline supplementation before exercise upregulates PGC-
1α expression in the skeletal muscle, resulting in a signiﬁcant
increase in skeletal muscle weight. A longer average time before
mice became exhausted during exercise was also observed in
l-citrulline-supplemented animals, but the signiﬁcance of this
eﬀect needs further veriﬁcation in a clinical trial. Furthermore,
inhibition of NOS expression suppresses the l-citrulline-induced
PGC-1α upregulation. Further experiments would aim to com-
pare the eﬀect of other amino acids to the eﬀect of l-citrulline on
enhancing exercise performance and increasing muscle weight.
This study has demonstrated that l-citrulline supplementation
resulted in a signiﬁcant improvement in exercise performance
and increased skeletal muscle weight, and therefore may be
used to enhance sports or exercise performance.
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